Tech Company Financing Transactions

Resolve Therapeutics Funding Round

Resolve Therapeutics closed a $5.8 million Series B funding round on 11/1/2012. Investors included New Science Ventures, Easton Capital and WRF Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

721 1st Ave. N
St. Petersburg, FL 33701
USA

Phone

Undisclosed

Website

www.resolvebio.com

Email Address

[email protected]

Overview

Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Peter Kiener

        

Chief Executive Officer

James Posada

        

VP - Manufacturing

Raj Dua

        

Browse more venture capital transactions:

Prev: 11/1/2012: Blue Box venture capital transaction
Next: 11/1/2012: Scratch Wireless venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary